Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

Jay, a concerned parent, discovers his third grader missed crucial science classes for nine weeks. School promises a ...

Cleveland-Cliffs, Inc. (NYSE: CLF) reported its third-quarter financial results before Monday’s opening bell. Below are the ...

Who is the Santa Cruz for? People who don't want to sacrifice quality, design, and handling to be able to move crap.

Cleveland-Cliffs reported Q3 2025 results with a revenue miss but maintained its loss per share in line with expectations.

Exchange-traded funds (ETFs) are the market's Swiss Army knife, capable of allowing average Joes and Janes to invest in a ...

Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...

The ASX 200 has risen against a falling gold price, with blue chip stocks fuelling a 0.41pc gain for the ... Read More The post Closing Bell: Market gains despite heavy gold sell down as prices dip ...